The Clinical and Translational Science Institute (CTSI) at the University of Pittsburgh is an integral part of a National Institutes of Health (NIH)-funded nationwide network whose charge is to speed new treatments to the people who need them. CTSI provides the support necessary to bridge the gap between innovative approaches to research and effective clinical and public health practice, health policy, and community engagement in research.
Since 2006, CTSI has worked to synthesize University-wide programs and new initiatives to promote a more comprehensive understanding—initially among members of the biomedical research/health care community, but also among the general public—of the tangible benefits to health practice that can be realized from clinical and translational research.
CTSI-supported programs and resources extend to all six of Pitt’s schools of the health sciences—and, through community engagement efforts, to the Pittsburgh region. Through the establishment of 10 core divisions, CTSI is building institutional infrastructure, including educational, programmatic, facility, and equipment resources, to support a wide range of clinical and translational research.
UPMC is an active partner in this initiative, providing important access to extensive clinical resources and potential research participants. CTSI also has established collaborative relationships with other Pittsburgh-area institutions, including the Urban League of Greater Pittsburgh, Carnegie Mellon University, and RAND Corporation.